News

PFAS concentrations in Los Angeles and Santa Ana rivers exceed federal safety limits, posing serious health risks to ...
Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.
In today’s health headlines, a physician-scientist tells us about liver cancer care here in New Haven, what your life may look like after certain liver cancer ...
Researchers at the Indian Institute of Science (IISc) have developed a unique luminescent probe that uses terbium, a rare earth metal, to sense the presence of an enzyme called β-glucuronidase, which ...
A liver ultrasound is quick, safe, painless, and relatively cheap. However, the definite diagnosis of your condition may require additional testing.
Researchers at IISc Bengaluru have developed a simple, low-cost light-based sensor using terbium to detect liver cancer. The ...
Traditional enzyme detection methods, such as colorimetry and fluorescence, often struggle with poor sensitivity or ...
The FDA has started a review of Bristol-Myers Squibb's immunotherapy duo Opdivo and Yervoy as a therapy for newly diagnosed unresectable liver cancer that could see a return to the category for ...
Chronic kidney disease (CKD) is typically associated with severe fibrosis, the exact pathogenesis of which remains unclear.
Liver fibrosis is the liver's response to injury, in which excess extracellular matrix is deposited. In most cases, liver fibrosis is the result of chronic liver disease, such as hepatitis.
Stimuli-triggered nanoplatforms have become attractive candidates for combined strategies for advanced liver cancer treatment. In this study, we designed a light-responsive nanoplatform with folic ...